Medical device maker Teleflex Inc said on Friday it agreed to buy Vascular Solutions Inc for about $1 billion.
-
Researchers in Spain create sperm from skin cells, potentially ending male infertility
-
More research volunteers are getting their medical test results. Should we cheer — or worry?
-
Zika may be spread by 2nd mosquito, researchers say, posing threat to Olympics
Teleflex's offer of $56 per Vascular share represents a premium of 1.6 percent to the stock's Thursday close.